PEAK6 Group’s Immunic IMUX Stock Holding History

PEAK6 Group’s Portfolio IMUX Stock Details IMUX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-78	Closed	-$357K	–	4687
2015 Q4	$357K	Sell	78 -420	-84%	-$1.37M	﹤0.01%	2926
2015 Q3	$804K	Buy	+498	New	+$2.49M	﹤0.01%	2431

Other funds holding IMUX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

RIM

RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Truvvo Partners New York $5.22M AUM 13.74% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

SRF

Silver Rock Financial Los Angeles, California $49.7M AUM 17.42% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

PEAK6 Group's IMUX Position: Q4 2015 in Review

PEAK6 Group sold out of Immunic (IMUX) in Q4 2015, closing a stake of 51 shares — an estimated $166K sold.

PEAK6 Group first reported a position in IMUX in Q3 2015 and held it in 1 quarter. The position peaked at $83K in Q3 2015. 54 funds tracked by Wall St. Rank hold IMUX as of Q4 2015.

PEAK6 Group reported no remaining Immunic position as of Q4 2015 after selling out during the quarter.
PEAK6 Group sold 51 Immunic shares in Q4 2015, an estimated $166K.
PEAK6 Group first reported a position in Immunic in Q3 2015 and held it in 1 quarter.
PEAK6 Group's Immunic position peaked at $83K in Q3 2015.
54 funds tracked by Wall St. Rank held Immunic as of Q4 2015.

Based on PEAK6 Group's 13F filing for Q4 2015, filed 16 Feb 2016.